Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 55

1.

Postpartum hyperprolactinemia and hyporesponsiveness of growth hormone (GH) to GH-releasing peptide.

de Zegher F, Spitz B, Van den Berghe G, Lemmens D, Vanweser K, Keppens K, Bowers CY.

J Clin Endocrinol Metab. 1998 Jan;83(1):103-6.

PMID:
9435424
2.

Short-term estradiol supplementation augments growth hormone (GH) secretory responsiveness to dose-varying GH-releasing peptide infusions in healthy postmenopausal women.

Anderson SM, Shah N, Evans WS, Patrie JT, Bowers CY, Veldhuis JD.

J Clin Endocrinol Metab. 2001 Feb;86(2):551-60.

PMID:
11158008
3.

Growth hormone isoforms in newborns and postpartum women.

Boguszewski CL, Boguszewski MC, de Zegher F, Carlsson B, Carlsson LM.

Eur J Endocrinol. 2000 Apr;142(4):353-8.

4.

Hexarelin, a synthetic growth hormone releasing peptide, stimulates prolactin secretion in acromegalic but not in hyperprolactinaemic patients.

Ciccarelli E, Grottoli S, Razzore P, Gianotti L, Arvat E, Deghenghi R, Camanni G, Ghigo E.

Clin Endocrinol (Oxf). 1996 Jan;44(1):67-71.

PMID:
8706295
5.

Neuroendocrine responses to a novel growth hormone secretagogue, L-692,429, in healthy older subjects.

Aloi JA, Gertz BJ, Hartman ML, Huhn WC, Pezzoli SS, Wittreich JM, Krupa DA, Thorner MO.

J Clin Endocrinol Metab. 1994 Oct;79(4):943-9.

PMID:
7962302
6.

Endocrine activities of ghrelin, a natural growth hormone secretagogue (GHS), in humans: comparison and interactions with hexarelin, a nonnatural peptidyl GHS, and GH-releasing hormone.

Arvat E, Maccario M, Di Vito L, Broglio F, Benso A, Gottero C, Papotti M, Muccioli G, Dieguez C, Casanueva FF, Deghenghi R, Camanni F, Ghigo E.

J Clin Endocrinol Metab. 2001 Mar;86(3):1169-74.

PMID:
11238504
8.

Pulsatile secretion of luteinizing hormone and prolactin in lactating and nonlactating women and the response to naltrexone.

Kremer JA, Borm G, Schellekens LA, Thomas CM, Rolland R.

J Clin Endocrinol Metab. 1991 Feb;72(2):294-300.

PMID:
1899421
9.

d-Lys-GHRP-6 does not modify the endocrine response to acylated ghrelin or hexarelin in humans.

Benso A, Prodam F, Lucatello B, Gramaglia E, Riganti F, Schneider H, van der Lely AJ, Muccioli G, Ghigo E, Broglio F.

Neuropeptides. 2007 Feb;41(1):45-9. Epub 2006 Nov 16.

PMID:
17112585
10.

Dynamics of pulsatile prolactin release during the postpartum lactational period.

Nunley WC, Urban RJ, Kitchin JD, Bateman BG, Evans WS, Veldhuis JD.

J Clin Endocrinol Metab. 1991 Feb;72(2):287-93.

PMID:
1991800
12.

Interaction of the growth hormone releasing peptide hexarelin with somatostatin.

Massoud AF, Hindmarsh PC, Brook CG.

Clin Endocrinol (Oxf). 1997 Nov;47(5):537-47.

PMID:
9425393
13.
15.
16.

Short-term recombinant human growth hormone therapy does not modify growth hormone, thyrotropin and prolactin responses to thyrotropin-releasing hormone in adult dialysis patients.

Iglesias P, Selgas R, Méndez J, Fernández-Reyes MJ, Bajo MA, Aguilera A, Díez JJ.

Nephrol Dial Transplant. 2000 Jun;15(6):856-61.

PMID:
10831641
17.

Oral administration of growth hormone (GH)-releasing peptide stimulates GH secretion in normal men.

Hartman ML, Farello G, Pezzoli SS, Thorner MO.

J Clin Endocrinol Metab. 1992 Jun;74(6):1378-84.

PMID:
1592884
19.
20.

Dose effect of human growth hormone-releasing factor and thyrotropin-releasing factor on hormone concentrations in lactating dairy cows.

Lapierre H, Petitclerc D, Pelletier G, Delorme L, Dubreuil P, Morisset J, Gaudreau P, Couture Y, Brazeau P.

Domest Anim Endocrinol. 1990 Oct;7(4):485-95.

PMID:
2124532

Supplemental Content

Support Center